missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ACROBiosystems SARS-CoV-2 Spike trimer protein-coupled magnetic beads
Click to view available options
Quantité:
2 mg
10 mg
Conditionnement:
10mg
2mg
Description
The pre-coupled magnetic beads coupled with biotinylated SARS-CoV-2 Spike trimer protein to streptavidin conjugated magnetic beads, which can capture the Anti- SARS-CoV-2 antibody or ACE2 protein from cell or serum sample. The SARS-CoV-2 Spike trimer protein, His Tag, Super stable trimer (SPN-C52H9) is the ectodomain of SARS-CoV-2 S protein which contains AA Val 16 - Pro 1213 (Accession # QHD43416.1). The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) and alanine substitutions (R683A and R685A) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein and abolish the furin cleavage site, respectively. The beads are in uniform size, narrow size distribution with large surface area and unique surface coating, which can help you get the best performance and highly reproducible results. This very first SARS-CoV-2 Spike trimer protein-coupled magnetic beads will bring great convenience with minimum non-specific binding and developed protocols. This ready to use products could greatly save your time and hassle.
Spécification
Spécification
| Contenus des kits | The Antigen pre-coupled magnetic beads are coupled with biotinylated protein onto streptavidin (SA) magnetic beads. Because Streptavidin (SA) has an extraordinarily high affinity for biotin with a dissociation constant (Kd) on the order of 10-14 mol/L, th |
| Contenu et stockage | -20°C, Avoid light |
| Conditions d’expédition | RT |
| Quantité | 2 mg |
| Type | Magnetic Affinity Bead |
| Espèces | SARS-CoV-2 |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu